You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Biotin
Greater than 95% as determined by reducing SDS-PAGE.
Mol Mass: 76.9 KDa. APMol Mass: 90-125 KDa
Human
Phe25-Glu698
C-Avi-6His
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 60.6 KDa. Observed: 90-120 KDa, reducing conditions
Human
Leu33-Trp320
C-Fc
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1&17.8 KDa. Observed: 15-22 KDa, reducing conditions
Human
Gly24-Ala155&Arg31-Gln163
C-Avi-6His
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.7 KDa. Observed: 38-50 KDa, reducing conditions
Human
Arg18Gly289
C-6His
10 μg, 50 μg, 500 μg, 1 mgBiotin
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 22.4 KDa. Observed: 24-26 KDa, reducing conditions
Human
His19-Val197
C-6His-Avi
100 μg, 20 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.8 KDa. Observed: 55-80 KDa, reducing conditions
Human
Gln19Gln333
C-Avi-6His
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 30-45 KDa, reducing conditions
Human
Ala22-His205
C-Avi-6His
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.1 KDa. Observed: 18-25 KDa, reducing conditions
Human
Ile56-Glu182
C-Avi-6His
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 31.4 KDa. Observed: 32-45 KDa, reducing conditions
Human
Leu21-Glu272
C-6His-Avi
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.1 KDa. Observed: 55-65 KDa, reducing conditions
Human
His29-Ser409
C-Avi-6His
20 μg, 100 μg